Layer-by-layer functionalized nanotube arrays: A versatile microfluidic platform for biodetection

We demonstrate the layer-by-layer (LbL) assembly of polyelectrolyte multilayers (PEM) on three-dimensional nanofiber scaffolds. High porosity (99%) aligned carbon nanotube (CNT) arrays are photolithographically patterned into elements that act as textured scaffolds for the creation of functionally c...

Full description

Bibliographic Details
Main Authors: Toner, Mehmet, Yost, Allison Lynne, Shahsavari, Setareh, Bradwell, Grinia M., Polak, Roberta, Fachin, Fabio, Cohen, Robert E, McKinley, Gareth H, Rubner, Michael F, Wardle, Brian L
Other Authors: Massachusetts Institute of Technology. Department of Aeronautics and Astronautics
Format: Article
Language:en_US
Published: Springer Nature 2017
Online Access:http://hdl.handle.net/1721.1/111955
https://orcid.org/0000-0003-2399-4397
https://orcid.org/0000-0003-4395-523X
https://orcid.org/0000-0003-3965-0740
https://orcid.org/0000-0003-1085-7692
https://orcid.org/0000-0001-8323-2779
https://orcid.org/0000-0003-3570-8917
https://orcid.org/0000-0003-3530-5819
Description
Summary:We demonstrate the layer-by-layer (LbL) assembly of polyelectrolyte multilayers (PEM) on three-dimensional nanofiber scaffolds. High porosity (99%) aligned carbon nanotube (CNT) arrays are photolithographically patterned into elements that act as textured scaffolds for the creation of functionally coated (nano)porous materials. Nanometer-scale bilayers of poly(allylamine hydrochloride)/poly(styrene sulfonate) (PAH/SPS) are formed conformally on the individual nanotubes by repeated deposition from aqueous solution in microfluidic channels. Computational and experimental results show that the LbL deposition is dominated by the diffusive transport of the polymeric constituents, and we use this understanding to demonstrate spatial tailoring on the patterned nanoporous elements. A proof-of-principle application, microfluidic bioparticle capture using N-hydroxysuccinimide-biotin binding for the isolation of prostate-specific antigen (PSA), is demonstrated.